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Abstract 
Severe acute respiratory syndrome coronavirus (SARS-CoV) 7a is an accessory protein 
with no known homologues. In this study, we report the interaction of a SARS-CoV 7a and 
small glutamine-rich tetratricopeptide repeat-containing protein (SGT). SARS-CoV 7a 
and human SGT interaction was identified using a two-hybrid system screen and 
confirmed with interaction screens in cell culture and cellular co-localization studies. The 
SGT domain of interaction was mapped by deletion mutant analysis and results indicated 
that tetratricopeptide repeat 2 (aa 125-158) was essential for interaction. We also showed 
that 7a interacted with SARS-CoV structural proteins M (membrane) and E (envelope), 
which have been shown to be essential for virus-like particle formation. Taken together, 
our results coupled with data from studies of the interaction between SGT and HIV-1 vpu 
indicated that SGT could be involved in the life-cycle, possibly assembly of SARS-CoV. 
 
Coronaviruses are members of the Coronaviridae family in the order Nidovirales. This 
family of viruses contains genomes of ~30 kb that include non-structural (pp1ab) and 
structural proteins (spike [S], envelope [E], membrane [M], and nucleocapsid [N]), 
making them the largest known RNA viruses. Interspersed among the structural proteins 
are group-specific proteins that differ in location and composition between the three 
coronavirus groups. The group-specific genes are not well characterized and the vast 
majority has, as yet, no known function. Initial research into the functions of these genes 
has shown that they are non-essential and dispensable for virus growth in cell culture [1]. 
However, more recent studies have shown that the accessory genes are required for in 
vivo infection in the natural host [2–4].  
 
Severe acute respiratory syndrome virus (SARS-CoV) encodes for eight potential open 
reading frames (ORFs), i.e., ORF 3a, 3b, 6, 7a, 7b, 8a, 8b, and 9b, with no known 
homologues [5–7]. Of these, SARS 3a, 3b, 6, 7a, and 9b have been detected in SARS-CoV 
infected cells, as well as in clinical samples [8], indicating possible in vivo functions. 
SARSCoV 7a (previously designated U122 in [9] and X4 in [10]) is the first ORF of 
subgenomic RNA 7 [6] and has been shown to be expressed inSARS-CoV infected Vero E6 
cells [9,11]. It has been shown to localize to the Golgi apparatus and the endoplasmic 
reticulum (ER) and is recycled between the ER and Golgi complex via the intermediate 
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compartments [9–11], where coronaviruses are known to bud [12]. Additionally, 7a has 
been shown to interact specifically with another unique SARS-CoV protein encoded by 
ORF3a (also called U274; [13]), which has been reported to be a novelSARS-CoV minor 
structural protein [14,15]. Interestingly, overexpression of 7a results in caspase-
dependent apoptosis in Vero E6, as well as in cells from the lung, kidney, and liver. 
Therefore, based on the clinical observation of apoptosis in tissues from different organs, 
it appears as though 7a contributes to apoptosis during SARS-CoV infection and possibly 
to the pathogenesis of SARS-CoV [16]. Recently, the structure of the N-terminal domain 
of 7a was resolved and reported to be similar in fold and topology to members of the Ig 
superfamily [11]. Taken together, results indicate that 7a could play an important role in 
the viral infection cycle, but the exact biological function(s) of 7a is yet to be determined. 
 
Identification of host proteins interacting with SARSCoV 7a could be vital in elucidating 
its possible functions. It could also provide crucial insight into the biology and 
pathogenicity of SARS-CoV. This is the first report of a cellular protein that interacts with 
SARS-CoV 7a. We used a yeast two-hybrid system to screen a B-lymphocyte Cdna 
expression library for cellular proteins capable of interacting with SARS-CoV 7a. The 
principal cDNA identified from the screen encoded a ~37.1 kDa peptide identified as 
human small glutamine-rich tetratricopeptide repeat (hSGT) containing protein. Our 
results indicated that 7a interacted with both human, as well as African Green monkey 
SGT (mSGT) from Vero E6 cells. The conceptual amino acid sequence of mSGT was 
determined and compared to the hSGT sequence; the amino acid (aa) sequence identity 
was found to be >99%. Protein–protein interaction was confirmed by co-
immunoprecipitation and immunofluorescent staining in Vero E6 cells, while the SGT 
domains involved in the interaction were mapped by deletion mutant analysis. 
Tetratricopeptide repeat (TPR) 2 of hSGT (aa 125-158) was shown to be crucial for this 
interaction. The biological significance of the interaction between SARS-CoV 7a and SGT 
needs to be elucidated.  
 
Materials and methods 
Two-hybrid system library screen. The yeast reporter strain AH109 [GAL4 2H-3] 
(Clontech) was used for the two-hybrid selection. Plasmid pAS2-7a∆96-122 (Table 1) was 
used as bait and a pACT-cDNA library (human lymphocyte MATCHMAKER, Clontech) 
was used as the source of prey genes. Yeast cells were grown on YPD or on synthetic 
minimal medium (0.67% yeast nitrogen base, the appropriate auxotrophic supplements, 
2% agar [for plates]) supplemented with 2% dextrose. Yeast was transformed with 
appropriate plasmids by the lithium acetate method and transformants were selected on 
synthetic minimal medium. The bait plasmid and the pB42AD cDNA library were 
introduced into the yeast strain AH109 [GAL4 2H-3]. Two-hybrid screen and interaction 
assays were performed essentially as described in the protocol (Clontech) in the presence 
of 2% galactose and 80 mg of 5-bromo-4-chloro-3-indolyl-Dgalactopyranoside per liter. 
Prey plasmids were selected from yeast colonies giving a positive signal according to the 
manufacturer’s protocol. False positives were eliminated by re-transforming the host 
AH109 [GAL4 2H-3] strain with pACT-cDNA library plus bait plasmid. Additionally, the 
pACT-cDNA was transfected in yeast strain PJ69-2A to check for autoactivation. The 
positive clones that contained cDNAs encoding 7ainteracting proteins were sequenced 





Mammalian cell lines and DNA constructs. African Green monkey kidney epithelial (Vero 
E6) cells (American Type Culture Collection, Manassas, USA) were maintained as 
described previously [9]. A cDNA clone expressing full-length 7a-HA were prepared as 
described previously [13]. A 7a-myc construct was prepared as in [13], but instead the 
amplicon was cloned into pXJ40-3’myc; all 7a proteins were epitope-tagged at the C-
terminus. Full length, as well as truncations of hSGT cDNA, tagged with an N-terminus 
flag epitope for expression in mammalian cells is summarized in Table 1. All cDNA 
sequences were confirmed by sequencing. 
 
Antibodies used. Glutathione S-transferase-hSGT (GST-hSGT) fusion protein was 
constructed to raise SGT-specific antibodies in mice and rabbits. The full-length hSGT 
was digested from pXJ40-flag-hSGT with BamHI and XhoI and cloned into the 
compatible sites of pGEX-4T-1. Fusion proteins were expressed in BL-21 Escherichia coli 
by induction with isopropyl-1-thio-L-D-galactopyranoside (IPTG) at 37 _C for 3 h. 
Subsequently, GST-hSGT was purified using Glutathione Sepharose beads (Pharmacia) 
and eluted with excess glutathione. Purified GSThSGT was then used to raise polyclonal 
antibodies in mice and rabbits, as described in [18]. Polyclonal (Santa Cruz) and 
monoclonal anti-HA (Roche) and anti-flag (Sigma) antibodies were used according to the 
manufacturer’s instructions. All procedures on animals were done in accordance with the 
regulations of the Animal Research Ethics Committee, Singapore. 
 
Transient expression and Western blotting. Vero E6 cells were transfected with 
Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer’s protocols. 
Unless stated otherwise, 1 µg of plasmid cDNA was used for transfection into Vero E6 
cells in transient expression studies; full-length flag-hSGT was used at 0.25 µg. Western 
blotting was done as described in [13]. 
 
Immunoprecipitation. Cell lysates were extracted from transfected Vero E6 cells as 
described above. Typically, 150 µg of whole cell lysates was incubated with either rabbit 
anti-flag or rabbit anti-SGT antibody conjugated to Protein A-agarose beads (Roche) for 




Following incubation, the beads were collected and complexes were washed three times 
with IP buffer. The bound proteins were eluted by boiling in SDS sample buffer and 




epithelial SGT. Total cellular RNA was extracted from Vero E6 cells using the RNeasy 
Mini Kit (Qiagen) according to the manufacturer’s instructions. First-strand cDNA was 
prepared from 1.0µg total RNA using the SuperScript II RNase Reverse Transcriptase kit 
(Invitrogen). Subsequently, a 1:10 dilution of the first-strand cDNA was used in a PCR 
according to standard protocols. The primary nucleotide sequence of African Green 
monkey kidney epithelial SGT (mSGT) was determined by automated sequencing and 
compared to the hSGT sequence (NCBI Accession No. NP_003012) using CLUSTAL X 
[19]. The conceptual amino acid sequence of mSGT was compared to hSGT and 
comparisons were visualized using GENEDOC software [20].  
Immunoflourescence. Transiently transfected Vero E6 cells were grown on coverslips. At 
about 16 h posttransfection, the medium was removed and the coverslips fixed in 
methanol at -20°C. After 5 min, the coverslips were lifted out and completely air-dried. 
Fixed cells were incubated with the primary antibody combination of mouse anti-HA and 
rabbit anti-flag at room temperature for 1 h. Mouse anti-HA and rabbit anti-flag antibody 
were used at a dilution of 1:200. Following washing, cells were incubated with the 
secondary antibody combination of FITC-conjugated goat antimouse and Rh-conjugated 
anti-rabbit antibodies at room temperature for 1 h (Santa Cruz Biochemicals, USA). 
Following extensive washing, the coverslips were mounted on glass slides and viewed.  
 
Results and discussion  
Identification of cellular proteins interacting with SARS-CoV 7a  
Biological processes are dependent on the direct physical interaction between different 
proteins. Therefore, the identification of host proteins that interact with viral accessory 
proteins could help elucidate possible functions of these unique viral proteins. In this 
study we used a yeast two-hybrid screen to identify host proteins that interacted with 7a. 
Truncated 7a (aa 1-96) protein—excluding the transmembrane-containing C-terminus to 
improve solubility of the expressed protein—was used as bait and 10 positive interacting 
candidates were identified. Following co-transformation and an autoactivation check to 
confirm the positive phenotypes, five clones were retained. The positive cDNA clones 
were sequenced and analyzed using BLAST; four of the positive clones contained 
complete ORFs that showed nucleotide sequence identity to human (h) SGT. hSGT 
identified in our screens encodes for a potential ORF of 313 amino acids (aa) with a 
predicted protein molecular mass of ~37.1 kDa and contained three 34 aa 
tetratricopeptide repeat (TPR) motifs.  
 
TPR motifs were first identified as protein interaction modules in cell division cycle 
proteins in yeast [21,22]. They have now been shown to be ubiquitous and present in a 
number of functionally distinct polypeptides from a variety of different species. Different 
protein–protein interactions are mediated by these motifs and the majority of TPR motif-
containing proteins have been shown to be involved in processes as diverse as cell cycle 
control, transcription and splicing events, protein transport and protein folding, to name 
a few [23]. The TPR-containing protein, hSGT, was first identified and described as a 
cellular binding partner for the non-structural (NS) protein of autonomous parvovirus H-
1. Interestingly, both H1-virus infection and transient expression of the NS protein result 
in modification (most likely phosphorylation) of hSGT [24]. A subsequent study showed 
that hSGT interacts with HIV-I Vpu and Gag proteins, with Callahan and co-workers 




partners of SGT include the growth hormone receptor [26], myostatin [27], heat shock 
cognate protein [28], and heat shock protein [29], and it has been speculated that SGT 
could also have a cochaperone function. Recently, it has been shown that SGT is present 
throughout the cell cycle and that depletion there-of leads to an increase in the mitotic 
index [30]. On the contrary, Wu and colleagues report that SGT is a pro-apoptotic factor 
and that knockdown of SGT expression in a hepatocarcinoma cell line protects against 
apoptotic stimuli [31]. It is clear that SGT has diverse functions within the different cell 
types and possibly plays a role in the life cycle of at least two human viruses.  
 
SGT interacts with SARS-CoV 7a in Vero E6 cells  
The mouse anti-SGT antibody specifically detected endogenous SGT from Vero E6 cells, 
as well as transfected flag-hSGT (Fig. 1A) and the polyclonal rabbit SGT antibody 
specifically immunoprecipitated endogenous Vero E6 SGT (Fig. 1B). Co-
immunoprecipitation studies were used to confirm the interaction between SGT and 7a-
HA in Vero E6 cells (Fig. 1B). Cells were co-transfected with pXJ40-flag-hSGT and 
pXJ40-7aHA, as described elsewhere. For 7a-HA interaction with endogenous Vero E6 
SGT, only pXJ40-7aHA was transfected. Total protein extracts were immunoprecipitated 
with either rabbit antiflag (lane 4) or rabbit anti-hSGT (lane 5) antibody conjugated to 
Protein A-agarose beads and Western blotted; an unrelated antibody (rabbit anti-myc, 
lane 6) was used as negative antibody control. Western blots and IP blots were detected 
with mouse anti-SGT and mouse anti-HA antibodies (Fig. 1B). SARS-CoV 7a-HA co-
immunoprecipitated with both flag-hSGT (lane 4), as well as with endogenous SGT from 
Vero E6 cells (lane 5). 7a-HA was not detected when the unrelated antibody (lane 6) was 
used for immunoprecipitation. Our results showed that 7a-HA interacted specifically with 
SGT from both human and monkey cells. 
 
To explain the interaction of 7a with both hSGT as well as African Green monkey SGT 
(mSGT), we determined the nucleotide sequence of mSGT using cDNA from Vero E6 
cells. The deduced primary amino acid sequence was compared to hSGT using CLUSTAL 
X [19] and visualized with GENEDOC [20]. mSGT showed >96% nucleotide and >99% aa 
sequence identity with hSGT (Fig. 2). This high sequence identity could explain why 7a-
HA interacted with SGT from two distinct organisms. 
 
SARS-CoV 7a co-localizes with flag-hSGT  
The sub-cellular localization of 7a-HA and flag-hSGT in Vero E6 cells was studied. Vero 
E6 cells were transfected with pXJ40-flag-hSGT and pXJ40-7aHA (Fig. 3). At 16 h post-
transfection, cells were fixed with methanol and stained with both mouse anti-HA and 
rabbit anti-flag antibodies. As a negative control untransfected Vero E6 cells were treated 
in the same way. Whereas 7a-HA showed a perinuclear localization (Fig. 3, middle panel), 
flag-hSGT was distributed to both the nucleus and cytoplasm of transfected cells (left 
panel) and untransfected cells did not stain (not shown) with the antibodies. The cellular 
distribution of SGT is consistent with a report by Cziepluch and coworkers [24] who 
found that untagged rat SGT is detectable in cytoplasm and nucleus of FREJ4 cells. Thus, 
7a-HA was found to partially co-localize with flag-hSGT in Vero E6 cells (right panel). 
This partial co-localization of flag-hSGT and 7a-HA indicated that SARS-CoV 7a could 







hSGT TPR2 is essential for the interaction with 7a  
Human small glutamine-rich tetratricopeptide contains three 34 aa TPR motifs that have 
been shown to mediate protein–protein interactions. In fact, recently Liou and Wang [32] 
investigated the functional importance of the different regions of SGT. They confirmed 
previous reports that the N-terminus of hSGT (aa 1-90) is responsible for self-
dimerization of the protein and that the TPR domain (aa 91-192) is important for 
interaction with different proteins. Furthermore, in in vitro studies the glutamine-rich C-
terminus portion (aa 193-313) could interact with short peptide segments consisting of 
consecutive non-polar amino acids. Thus, to determine whether the TPR motifs played a 
role in the interaction between hSGT and SARS-CoV 7a, four hSGT deletion mutants were 
created (Fig. 4A). Binding of the hSGT mutants with 7a-HA was studied using 
immunoprecipitation assays in Vero E6 cells. Results showed that full-length flag-hSGT 
(aa 1-313), flag-hSGT∆C (aa 1-192), and flag-hSGT∆C3 (aa 1-158) interacted with 7a-HA 
in Vero E6 cells. On the other hand, flag-hSGT∆N1-2 (aa 159-313) and flag-hSGT∆C3-2 
(aa1-125) did not interact with 7a-HA (Fig. 4B). Also, the negative control flag-GST did 
not interact with 7a-Ha. Since only full-length and SGT mutants that contain TPR2 
interacted with 7a, our results showed that TPR2 (aa 125-158) was essential for the 
interaction.  
 
7a-HA interacted with SARS-CoV M and E  
7a-HA has previously been shown to interact with the SARS-CoV minor structural protein 
3a [13]. Co-immunoprecipitation studies in Vero E6 cells were used to determine whether 
7a-myc also interacted with the SARS-CoV structural proteins (nucleocapsid) N, M, and E 
(Fig. 5). In this study, the HA-tagged proteins HA-N, M-HA, and E-HA were used as 









Whereas, the N protein is responsible for packaging the RNA into the nucleocapsid, the M 
and E proteins are responsible for virus assembly. In fact, the co-expression of M and E in 
a baculovirus expression system was sufficient for the assembly of virus-like particles 
[33]. Results showed that 7a-myc (aa 1-122) indeed interacted with HA-M (lane 4) and E-
HA (lane 6), but not with HA-N (lane 2). There was no interaction between the negative 
control myc-GST and HA-N, M-HA or E-HA (lanes 1, 3, and 5). The interaction of SGT 
with the HIV-1 accessory protein vpu and major structural protein gag has previously 
been reported [25]. The accessory protein vpu has been shown to be essential in 




and subsequent association with vpu protein reduces the titre of virus released from HIV-
1 infected cells [25]. The authors also reported that the in vivo interaction between gag 
and SGT was abrogated when vpu was overexpressed in cells, indicating an intricate 
relationship between SGT, the accessory protein and the major structural protein. In this 
study, we reported the interaction of SARS-CoV 7a with hSGT. To our knowledge, this is 




The interaction was confirmed by co-immunoprecipitation and immunofluorescent 
studies in VeroE6 cells. We concluded that TPR2 of hSGT (aa 125-158) was essential for 
the interaction between SGT and SARS-CoV 7a.We also showed that 7a interacted with 
SARS-CoV M and E. Based on recent reports, it is clear that the SARS-CoV accessory 
proteins are probably involved in various viral processes in vivo, including pathogenicity 
and infectivity. In showing that 7a interacted with SGT, a protein with many diverse and 
essential functions, our findings provided further evidence in support of this hypothesis. 
Our data raised the possibility that the interaction between SGT and 7a, and the latter’s 




could play a role in virus assembly or release from the cell. Understanding the biological 
significance of the interaction between SGT and 7a could possibly lead to the discovery of 
novel therapeutics in treating SARSCoV infection. 
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